Table 4.
AN total sample (n = 139) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
T0 | EOT | Test statistics | |||||||||||
R-AN (n = 96) | BP-AN (n = 43) | R-AN (n = 96) | BP-AN (n = 43) | Within subjects | Between subjects | Group × time | |||||||
Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | F | p | η 2 | F | p | η 2 | F | p | η 2 | |
BSQ | 113.4 (44.6) | 142.9 (43.3) | 105.5 (46.4) | 127.7 (45.6) | 15.323 | <0.001 | 0.126 | 9.579 | 0.003 | 0.083 | 4.246 | 0.042 | 0.039 |
BCQ | 57.5 (27.2) | 66.6 (27.6) | 55.9 (27.5) | 65.7 (28.3) | 0.484 | 0.488 | 0.004 | 3.641 | 0.059 | 0.032 | 0.112 | 0.738 | 0.001 |
BIAQ | 41.1 (18.3) | 47.4 (18) | 36.1 (17.1) | 43.2 (17.7) | 15.571 | <0.001 | 0.129 | 5.130 | 0.026 | 0.047 | 0.307 | 0.581 | 0.003 |
Abbreviations: BCQ, Body Checking Questionnaire; BIAQ, Body Avoidance Questionnaire; BSQ, Body Shape Questionnaire; EOT, end of treatment; η 2, eta squared.
0.01–0.06 = small effect; 0.06–0.14 = moderate effect; >0.14 = large effect.
statistical significance (p < 0.05) has been highlighted in bold.